NEW YORK (TheStreet) -- Shares of Eli Lilly and Co. are up 0.79% to $71.53 today ahead of the company's fourth-quarter earnings report expected before the market open tomorrow. The consensus estimate calls for Eli Lilly to report earnings of 75 cents a share on revenue of $5.2 billion. In the fourth quarter last year, the company posted earnings of 74 cents a share, in line with consensus estimates, according to analysts polled by Thomson Reuters. Revenue totaled $5.81 billion, above analysts' estimates of $5.46 billion. Exclusive Report: Jim Cramer's Best Stocks for 2015 STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. In the third quarter of 2014, Eli Lilly posted EPS of 66 cents a share, below the consensus estimate of 67 cents a share. Revenue totaled $4.88 billion, above estimates of $4.83 billion. Barclays recently rated the stock "equal weight" and raised its price target to $69 from $63. LLY data by YCharts STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Click to view a price quote on LLY. Click to research the Drugs industry.
from Latest TSC Headlines http://ift.tt/1z9lRb0
No comments:
Post a Comment